CompassRx

What CompassRx does

CompassRx is an AI-powered platform serving U.S. healthcare providers that participate in the federal 340B Drug Pricing Program. Founded in 2024 by a team combining AI specialists with 340B program experts, the company deploys proprietary AI agents that automate operational workflows including patient capture and engagement, referral capture, compliance review, 340B auditing, opportunity analytics, and pharmacy capture. The technology stack combines large language models, computer vision, voice models, and multimodal AI to process unstructured medical documents, auto-generate prior authorizations, perform real-time analytics, and enable multilingual patient-provider communication, with human-in-the-loop review for compliance-critical cases.

The company targets four covered-entity segments: Disproportionate Share Hospitals (DSHs), rural hospitals, Federally Qualified Health Centers (FQHCs), and Ryan White Clinics. CompassRx's solutions are positioned against three structural pressures: pharmacist staffing shortages (the U.S. has seen a 60% decline in pharmacy school applicants since 2012), HRSA-driven audit and compliance burden, and revenue erosion caused by contract pharmacy restrictions imposed by 40+ drug manufacturers. Named reference customers include a Northeast-based health system citing 50 unfilled pharmacy positions, a Midwest rural health system pivoting away from contract pharmacies, and an independent pharmacy serving Ryan White Clinics.

CompassRx operates a subscription-based revenue model distributed through direct enterprise field sales to Chief Pharmacy Officers and Directors of Pharmacy. Go-to-market is domestic only and is supplemented by content marketing (blog, email newsletter), webinars, and active presence at 340B Coalition events, alongside a content partnership with 340B Report. Pricing is not publicly disclosed and the company offers free AI strategy consultations as an entry point. The organization has approximately 5 employees, no disclosed funding rounds, and operates as a private company.

Name

CompassRx

Website

https://compassrx.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

340B Pharmacy Compliance Software

NAICS

Custom Computer Programming Services (541511)

akta.pro primary industry

Medication Pricing, Copay Assistance & Patient Financial Support Tools (HLACAKAN)

Keywords

• 340B program software
• Hospital pharmacy AI
• Pharmacy automation agents
• Healthcare procurement software
• 340B compliance platform

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. AI Services for Hospital Pharmacies: CompassRx provides AI-powered services to grow hospital pharmacies by improving prescription volume, medication adherence, and patient outcomes. Services are offered to healthcare organizations including hospitals, health centers, and clinics participating in the 340B program.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

Core offering

CompassRx provides an AI-powered platform composed of specialized AI agents that automate hospital pharmacy workflows, with a primary focus on 340B Drug Pricing Program compliance, prior authorization, procurement, claims, inventory, compounding, demand forecasting, and HR tasks. Customers can subscribe to individual agents or to the full pharmacy-level package on a transparent, per-agent or per-pharmacy fee structure.

Product overview

CompassRx is an AI-powered platform for the pharmacy industry, specifically focused on the 340B program. The platform offers a unified set of AI solutions comprising Patient Capture and Engagement, Referral Capture, and Compliance Review, with supporting features including 340B Auditing, Opportunity Analytics, and Pharmacy Capture. The core services include Increasing Pharmacy Capture, Medication Optimization and Adherence, and Personalized Clinical and Financial Support. All solutions leverage proprietary AI agents to automate operational tasks, improve prescription volume, medication adherence, and patient outcomes.

Differentiator

Problem solved

Functional benefit

Products and services

• Aurora

Quantifiable outcome

• AI agents can audit entire systems including unstructured data like medical documents, flagging cases for human review
• +2 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability10 records

Feature8 records

Partnerships

Two partnerships are on record, tiered core.

• 340B ReportcoreGTM or Marketing Partner · 25 March 2025Ted Slafsky, Publisher and CEO of 340B Report, collaborates with CompassRx CEO Ali Farzad on educational webinars about AI in the 340B space. This partnership positions CompassRx within the trusted 340B information ecosystem and leverages Ted Slafsky's industry credibility to reach covered entity decision-makers.
• 340B CoalitioncoreStrategic or Co-development PartnerCompassRx actively participates in 340B Coalition events including the winter conference. The company uses these forums to engage with the 340B community, understand evolving challenges, and position their AI solutions for covered entities navigating the changing regulatory landscape.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Emerging players

• Cohere Health: AI-driven prior authorization and utilization management platform for payers and providers. Directly comparable to CompassRx's prior-auth auto-generation feature, and a relevant emerging AI-native healthcare workflow peer.

Broad incumbents

• Omnicell: Large medication management and pharmacy automation vendor that owns Sentry Data Systems. Competes at the platform layer into which CompassRx's 340B-specific AI plugs, and can bundle or displace standalone tools.
• Epic Systems: Dominant EHR vendor for large U.S. health systems and a key workflow layer for hospital pharmacy and 340B operations. Represents the largest incumbent distribution channel CompassRx must integrate with or compete against.
• Oracle Health (Cerner): Major EHR and healthcare IT vendor with broad hospital system footprint. Comparable buyer base and growing embedded AI capabilities that could encroach on CompassRx's workflow automation layer.
• McKesson: Pharma distributor and healthcare services giant with significant 340B-related offerings, including CoverMyMeds for prior authorization. Broad incumbent that competes in adjacent pharmacy workflow software.

Direct peers

• Sentry Data Systems (Omnicell 340B): Long-standing 340B compliance and analytics platform, now part of Omnicell. Comparable on 340B audit, compliance, and opportunity analytics — the exact workflows CompassRx is automating with AI.
• Verity Solutions: Established 340B management software vendor serving covered entities with split-billing, compliance, and audit tools. Closest direct comparable: also targets DSHs, FQHCs, and rural hospitals with workflow software for the 340B program.
• CPS Solutions: Hospital pharmacy management and 340B services company providing staffing, compliance, and operational support to health systems. Comparable buyer (hospital pharmacy leadership) and overlapping 340B operations focus.
• Macro Helix (Sun River): Specialist 340B software platform providing split-billing, contract pharmacy management, and audit support. Directly comparable to CompassRx on 340B-specific functionality and covered-entity customer base.

Others

• Apexus (340B Prime Vendor): HRSA-designated 340B Prime Vendor Program administrator offering Apexus 340B University, compliance tools, and industry education. Not a competitor but the central ecosystem enabler and trusted educator CompassRx partners with.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/compassrx

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CompassRx